lundi 21 septembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 26, 2026

Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus

View original at finance.yahoo.com
Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus Major U.S. indexes like the Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average rallied 2.4%, 1.8%, and 1.3%, respectively, during holiday-shortened trading last week…
Opening lines of the source · short snapshot — read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Over 10-year period (2016-2025), equal-weight Zacks Rank #1 stocks portfolio outperformed equal-weight S&P 500 by more than 7 percentage points (+18.55% vs. +11.65%)

    80% confidence
  • Zacks ECDP returned -2.1% in Q4 2025 vs. S&P 500's +2.7% gain and NOBL's +1.6% return

    80% confidence
  • Fresh tariff threats to countries opposing acquisition of Greenland

    80% confidence
  • Zacks ECAP returned +16.26% in 2024 vs. +24.89% for S&P 500

    80% confidence
  • Zacks ECAP returned -1.67% for full year 2025 vs. S&P 500's +17.9% gain

    80% confidence
  • Zacks ECDP returned -0.6% in 2025 vs. +6.8% for NOBL

    80% confidence
  • Zacks Focus List portfolio returned -15.2% in 2022 vs. S&P 500's -17.96%

    80% confidence
  • Since 2012, Top 10 portfolio produced cumulative return of +2,472.7% vs. +561.6% for S&P 500 and +403.3% for equal-weight version

    80% confidence
  • Zacks ECAP portfolio returned -2.3% in Q4 2025 vs. S&P 500's +2.7% gain

    80% confidence
  • Suggested a collaborative framework for Greenland during World Economic Forum at Davos summit

    80% confidence
  • Zacks Focus List portfolio returned +18.41% in 2024 vs. +25.04% for S&P 500 and +13% for equal-weight S&P 500

    80% confidence
  • Zacks Top 10 portfolio returned +62.98% in 2024 vs. +25.04% for S&P 500 and +13% for equal-weight version

    80% confidence
  • Hypothetical equal-weight portfolio returned +22.4% in 2024 vs. +13.7% for the equal-weight S&P 500 index

    80% confidence
  • Top 10 portfolio produced average annual return of +25.8% from 2012 through 2025 vs. +13.1% for S&P 500 and +10.5% for equal-weight version

    80% confidence
  • Zacks Focus List portfolio returned +22.1% in 2025 vs. +17.9% for the S&P 500 index and +11.4% for equal-weight version

    80% confidence
  • Equal-weight portfolio of Zacks Rank #1 stocks outperformed the equal-weight S&P 500 index by 7 percentage points (+17.81% vs. +10.85%)

    80% confidence
  • Zacks Focus List portfolio returned +29.54% in 2023 vs. +26.28% for S&P 500 and +13.61% for equal-weight S&P 500

    80% confidence
  • Zacks Top 10 portfolio returned +22.6% in 2025 vs. +17.9% for S&P 500 and +11.4% for equal-weight version

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Notre lecture des données ›
Signaux que nous suivons
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Tendances que nous surveillons ›
Là où les sources divergent
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
Nous signalons les conflits ouvertement ›
Vérifié récemment
Vérifié avec la source d'origine
4,982
faits reliés à leur source — et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,982 faits vérifiés avec la source5,299 documents sources archivés
Interrogez ces données → isubstrate.com
Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus — Source | Via News | fr.VIA.NEWS